Check-Cap Ltd. (NASDAQ:CHEK) Sees Large Growth in Short Interest

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 113,000 shares, a growth of 1,041.4% from the December 31st total of 9,900 shares. Currently, 2.6% of the shares of the stock are short sold. Based on an average trading volume of 1,210,000 shares, the days-to-cover ratio is currently 0.1 days.

Check-Cap Price Performance

Shares of CHEK opened at $0.99 on Thursday. Check-Cap has a one year low of $0.56 and a one year high of $3.45. The company has a 50-day moving average of $1.07 and a two-hundred day moving average of $1.41. The stock has a market cap of $5.79 million, a price-to-earnings ratio of -0.33 and a beta of 0.17.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on Check-Cap in a report on Tuesday. They set a “sell” rating for the company.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.